Literature DB >> 3043924

Cocaine: analysis, pharmacokinetics, and metabolic disposition.

P Jatlow1.   

Abstract

The ability to measure concentrations of cocaine in body fluids can contribute substantially to any investigation of cocaine's pharmacological effects. Design of research which involves the administration of cocaine must take into account current knowledge regarding the drug's pharmacokinetics. Cocaine's very rapid elimination from the body should be considered in attempting to understand patterns of cocaine abuse, and such phenomena as bingeing and acute tolerance. Accurate analysis of cocaine and/or its metabolites is essential to the diagnosis and evaluation of cocaine use whether for medical or forensic purposes. Appropriate selection of methods for analysis of cocaine depends upon the intended purpose of the assay, and correct interpretation of the data obtained upon knowledge of cocaine's kinetics and metabolic disposition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3043924      PMCID: PMC2590277     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  32 in total

1.  Hydrolysis of cocaine in human plasma by cholinesterase.

Authors:  D J Stewart; T Inaba; B K Tang; W Kalow
Journal:  Life Sci       Date:  1977-05-01       Impact factor: 5.037

2.  Oral cocaine: plasma concentrations and central effects.

Authors:  C Van Dyke; P Jatlow; J Ungerer; P G Barash; R Byck
Journal:  Science       Date:  1978-04-14       Impact factor: 47.728

3.  Evaluation of the radioimmunoassay for benzoylecgonine (a cocaine metabolite) in human urine.

Authors:  S J Mulé; D Jukofsky; M Kogan; A De Pace; K Verebey
Journal:  Clin Chem       Date:  1977-05       Impact factor: 8.327

4.  Measurement of benzoylecgonine and cocaine in urine, separation of various cocaine metabolites using reversed-phase high-performance liquid chromatography.

Authors:  P I Jatlow; C Van Dyke; P Barash; R Byck
Journal:  J Chromatogr       Date:  1978-05-11

5.  Cocaine-induced hepatotoxicity in mice.

Authors:  M A Evans; R D Harbison
Journal:  Toxicol Appl Pharmacol       Date:  1978-09       Impact factor: 4.219

6.  Thin-layer chromatographic analysis of cocaine and benzoylecgonine in urine.

Authors:  J E Wallace; H E Hamilton; H Schwertner; D E King; J L McNay; K Blum
Journal:  J Chromatogr       Date:  1975-11-26

7.  Cocaine: plasma concentrations after intranasal application in man.

Authors:  C Van Dyke; P G Barash; P Jatlow; R Byck
Journal:  Science       Date:  1976-02-27       Impact factor: 47.728

8.  Cocaine plasma concentration: relation to physiological and subjective effects in humans.

Authors:  J I Javaid; M W Fischman; C R Schuster; H Dekirmenjian; J M Davis
Journal:  Science       Date:  1978-10-13       Impact factor: 47.728

9.  Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases.

Authors:  D J Stewart; T Inaba; M Lucassen; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

10.  Metabolism of cocaine in man.

Authors:  T Inaba; D J Stewart; W Kalow
Journal:  Clin Pharmacol Ther       Date:  1978-05       Impact factor: 6.875

View more
  17 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration.

Authors:  Karl B Scheidweiler; Erin A Kolbrich Spargo; Tamsin L Kelly; Edward J Cone; Allan J Barnes; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2010-10       Impact factor: 3.681

3.  Intrauterine cocaine, lead, and nicotine exposure and fetal growth.

Authors:  D R Neuspiel; M Markowitz; E Drucker
Journal:  Am J Public Health       Date:  1994-09       Impact factor: 9.308

4.  Citalopram enhances cocaine's subjective effects in rats.

Authors:  Paul L Soto; Takato Hiranita; Jonathan L Katz
Journal:  Behav Pharmacol       Date:  2009-12       Impact factor: 2.293

5.  Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene.

Authors:  E F McCance-Katz; L H Price; C J McDougle; T R Kosten; J E Black; P I Jatlow
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Cocaine is pharmacologically active in the nonhuman primate fetal brain.

Authors:  Helene Benveniste; Joanna S Fowler; William D Rooney; Bruce A Scharf; W Walter Backus; Igor Izrailtyan; Gitte M Knudsen; Steen G Hasselbalch; Nora D Volkow
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

7.  Cocaine and metabolite concentrations in DBS and venous blood after controlled intravenous cocaine administration.

Authors:  Kayla N Ellefsen; Jose Luiz da Costa; Marta Concheiro; Sebastien Anizan; Allan J Barnes; Sandrine Pirard; David A Gorelick; Marilyn A Huestis
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

8.  Cocaine-related vascular headaches.

Authors:  A Dhuna; A Pascual-Leone; M Belgrade
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

9.  Custody of cocaine-exposed newborns: determinants of discharge decisions.

Authors:  D R Neuspiel; T M Zingman; V H Templeton; P DiStabile; E Drucker
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

10.  A second-generation vaccine protects against the psychoactive effects of cocaine.

Authors:  M R Carrera; J A Ashley; P Wirsching; G F Koob; K D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.